Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 168110-44-9
2. Fr179642
3. Fr-179642
4. Micafungin Fr-179642 Impurity
5. 44677o2tdo
6. Fr-133303
7. Pneumocandin A0, 1-[(4r,5r)-4,5-dihydroxy-l-ornithine]-4-[(4s)-4-hydroxy-4-[4-hydroxy-3-(sulfooxy)phenyl]-l-threonine]-
8. [5-[(1s,2s)-2-[(3s,6s,9s,11r,15s,18s,20r,21r,24s,25s,26s)-18-amino-3-[(1r)-3-amino-1-hydroxy-3-oxopropyl]-11,20,21,25-tetrahydroxy-15-[(1r)-1-hydroxyethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-6-yl]-1,2-dihydroxyethyl]-2-hydroxyphenyl] Hydrogen Sulfate
9. 1-((4r,5r)-4,5-dihydroxy-l-ornithine)-4-((4s)-4-hydroxy-4-(4-hydroxy-3-(sulfooxy)phenyl)-l-threonine)pneumocandin A0
10. Pneumocandin A0, 1-((4r,5r)-4,5-dihydroxy-l-ornithine)-4-((4s)-4-hydroxy-4-(4-hydroxy-3-(sulfooxy)phenyl)-l-threonine)-
11. Pneumocandin A0, 1-((4r,5r)-4,5-dihydroxy-l-ornithine)-4-((s)-4-hydroxy-4-(4-hydroxy-3-(sulfooxy)phenyl)-l-threonine)-
12. Fr 179642
13. Unii-44677o2tdo
14. Schembl14515067
15. Ex-a2749
16. Zinc299872166
17. Hy-129077
18. Cs-0103490
19. 5-((1s,2s)-2-((2r,6s,9s,11r,12r,14as,15s,16s,20s,23s,25as)-9-amino-20-((r)-3-amino-1-hydroxy-3-oxopropyl)-2,11,12,15-tetrahydroxy-6-((r)-1-hydroxyethyl)-16-methyl-5,8,14,19,22,25-hexaoxotetracosahydro-1h-dipyrrolo[2,1-c:2',1'-l][1,4,7,10,13,16]hexaazacyclohenicosin-23-yl)-1,2-dihydroxyethyl)-2-hydroxyphenyl Hydrogen Sulfate
Molecular Weight | 936.9 g/mol |
---|---|
Molecular Formula | C35H52N8O20S |
XLogP3 | -9.3 |
Hydrogen Bond Donor Count | 16 |
Hydrogen Bond Acceptor Count | 21 |
Rotatable Bond Count | 9 |
Exact Mass | 936.30185725 g/mol |
Monoisotopic Mass | 936.30185725 g/mol |
Topological Polar Surface Area | 480 Ų |
Heavy Atom Count | 64 |
Formal Charge | 0 |
Complexity | 1860 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 15 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Shanghai Minbiotech is the leading producer of biopharmaceuticals and a variety of high-end generic & innovative drugs.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 27434
Submission : 2013-08-29
Status : Active
Type : II
Shanghai Minbiotech is the leading producer of biopharmaceuticals and a variety of high-end generic & innovative drugs.
About the Company : Headquartered in Fengxian District, Shanghai Minbiotech Co., Ltd. is a company specializing in the R&D and production of advanced pharmaceutical intermediates and biological API...
About the Company : Zhejiang Huida Biotech Co., Ltd. is located in Hangzhou, Zhejiang Province. It was established in 2020 and is a holding subsidiary of Huadong Medicine Co., Ltd. The company focu...
ABOUT THIS PAGE
A FR 179642 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of FR 179642, including repackagers and relabelers. The FDA regulates FR 179642 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. FR 179642 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of FR 179642 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A FR 179642 supplier is an individual or a company that provides FR 179642 active pharmaceutical ingredient (API) or FR 179642 finished formulations upon request. The FR 179642 suppliers may include FR 179642 API manufacturers, exporters, distributors and traders.
click here to find a list of FR 179642 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A FR 179642 DMF (Drug Master File) is a document detailing the whole manufacturing process of FR 179642 active pharmaceutical ingredient (API) in detail. Different forms of FR 179642 DMFs exist exist since differing nations have different regulations, such as FR 179642 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A FR 179642 DMF submitted to regulatory agencies in the US is known as a USDMF. FR 179642 USDMF includes data on FR 179642's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The FR 179642 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of FR 179642 suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing FR 179642 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for FR 179642 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture FR 179642 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain FR 179642 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a FR 179642 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of FR 179642 suppliers with NDC on PharmaCompass.
FR 179642 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of FR 179642 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right FR 179642 GMP manufacturer or FR 179642 GMP API supplier for your needs.
A FR 179642 CoA (Certificate of Analysis) is a formal document that attests to FR 179642's compliance with FR 179642 specifications and serves as a tool for batch-level quality control.
FR 179642 CoA mostly includes findings from lab analyses of a specific batch. For each FR 179642 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
FR 179642 may be tested according to a variety of international standards, such as European Pharmacopoeia (FR 179642 EP), FR 179642 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (FR 179642 USP).
LOOKING FOR A SUPPLIER?